Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2105
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors ; volume:12 ; number:14 ; day:14 ; month:12 ; year:2011 ; pages:1-14 ; date:12.2011
BMC bioinformatics ; 12, Heft 14 (14.12.2011), 1-14, 12.2011
- Urheber
-
John, Shalini
- Beteiligte Personen und Organisationen
-
Thangapandian, Sundarapandian
Arooj, Mahreen
Hong, Jong Chan
Kim, Kwang Dong
Lee, Keun Woo
SpringerLink (Online service)
- DOI
-
10.1186/1471-2105-12-S14-S4
- URN
-
urn:nbn:de:1111-2016021731412
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- John, Shalini
- Thangapandian, Sundarapandian
- Arooj, Mahreen
- Hong, Jong Chan
- Kim, Kwang Dong
- Lee, Keun Woo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression
In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum
In silico screening for identification of novel β-1,3-glucan synthase inhibitors using pharmacophore and 3D-QSAR methodologies
Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations
Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation
The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies
QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach
QSAR analysis on tacrine-related acetylcholinesterase inhibitors
New sirtuin modulators: their uncovering, pharmacophore, and implications in drug discovery
Machine learning accelerates pharmacophore-based virtual screening of MAO inhibitors
Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression
In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum
In silico screening for identification of novel β-1,3-glucan synthase inhibitors using pharmacophore and 3D-QSAR methodologies
Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations
Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation
The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies
QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach
QSAR analysis on tacrine-related acetylcholinesterase inhibitors
New sirtuin modulators: their uncovering, pharmacophore, and implications in drug discovery
Machine learning accelerates pharmacophore-based virtual screening of MAO inhibitors
Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression
In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum
In silico screening for identification of novel β-1,3-glucan synthase inhibitors using pharmacophore and 3D-QSAR methodologies
Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations
Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation
The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies
QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach
QSAR analysis on tacrine-related acetylcholinesterase inhibitors
New sirtuin modulators: their uncovering, pharmacophore, and implications in drug discovery